Immediate Impact
1 from Science/Nature 72 standout
Citing Papers
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
Works of M.-C. Brindisi being referenced
European Association for the Study of the Liver (EASL ), European Association for the Study of Diabetes (EASD ) and European Association for the Study of Obesity (EASO ) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M.-C. Brindisi | 169 | 35 | 258 | 101 | 12 | 349 | |
| Richard Guerrero | 151 | 60 | 238 | 80 | 11 | 347 | |
| Ruveena Bhavani Rajaram | 121 | 31 | 277 | 130 | 13 | 389 | |
| Hilde Løland von Volkmann | 182 | 26 | 257 | 71 | 13 | 347 | |
| Keitarou Kawasaki | 175 | 24 | 192 | 53 | 14 | 408 | |
| Jeffrey R. Lewis | 104 | 40 | 242 | 65 | 13 | 402 | |
| Valerio Nobili | 195 | 22 | 302 | 82 | 9 | 394 | |
| Hemant Chatrath | 97 | 36 | 248 | 129 | 10 | 384 | |
| Mohammad Nasser Kabbany | 142 | 36 | 320 | 165 | 20 | 367 | |
| Efthimia Zafeiriadou | 157 | 28 | 245 | 73 | 9 | 336 | |
| Tolga Yakar | 113 | 73 | 179 | 85 | 20 | 374 |
All Works
Loading papers...